Kassberg Thomas Richard 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Mar 15, 2022
Insider Transaction Report
Form 4
Kassberg Thomas Richard
CBO & Senior Vice President
Transactions
- Sale
Common Stock
2022-03-11$67.01/sh−10,281$688,930→ 227,559 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.